364 related articles for article (PubMed ID: 24631357)
21. Hepatitis C Virus Activates a Neuregulin-Driven Circuit to Modify Surface Expression of Growth Factor Receptors of the ErbB Family.
Stindt S; Cebula P; Albrecht U; Keitel V; Schulte am Esch J; Knoefel WT; Bartenschlager R; Häussinger D; Bode JG
PLoS One; 2016; 11(2):e0148711. PubMed ID: 26886748
[TBL] [Abstract][Full Text] [Related]
22. Effect of epiregulin on pancreatic beta cell growth and insulin secretion.
Kuntz E; Broca C; Komurasaki T; Kaltenbacher MC; Gross R; Pinget M; Damgé C
Growth Factors; 2005 Dec; 23(4):285-93. PubMed ID: 16338791
[TBL] [Abstract][Full Text] [Related]
23. Negative constraints underlie the ErbB specificity of epidermal growth factor-like ligands.
van der Woning SP; van Rotterdam W; Nabuurs SB; Venselaar H; Jacobs-Oomen S; Wingens M; Vriend G; Stortelers C; van Zoelen EJ
J Biol Chem; 2006 Dec; 281(52):40033-40. PubMed ID: 17032651
[TBL] [Abstract][Full Text] [Related]
24. Epiregulin, a novel member of the epidermal growth factor family, is an autocrine growth factor in normal human keratinocytes.
Shirakata Y; Komurasaki T; Toyoda H; Hanakawa Y; Yamasaki K; Tokumaru S; Sayama K; Hashimoto K
J Biol Chem; 2000 Feb; 275(8):5748-53. PubMed ID: 10681561
[TBL] [Abstract][Full Text] [Related]
25. Mode of oocyte maturation affects EGF-like peptide function and oocyte competence.
Richani D; Ritter LJ; Thompson JG; Gilchrist RB
Mol Hum Reprod; 2013 Aug; 19(8):500-9. PubMed ID: 23594928
[TBL] [Abstract][Full Text] [Related]
26. Tumor endothelial cells express epidermal growth factor receptor (EGFR) but not ErbB3 and are responsive to EGF and to EGFR kinase inhibitors.
Amin DN; Hida K; Bielenberg DR; Klagsbrun M
Cancer Res; 2006 Feb; 66(4):2173-80. PubMed ID: 16489018
[TBL] [Abstract][Full Text] [Related]
27. Ligand stimulation of ErbB4 and a constitutively-active ErbB4 mutant result in different biological responses in human pancreatic tumor cell lines.
Mill CP; Gettinger KL; Riese DJ
Exp Cell Res; 2011 Feb; 317(4):392-404. PubMed ID: 21110957
[TBL] [Abstract][Full Text] [Related]
28. Epiregulin is a potent vascular smooth muscle cell-derived mitogen induced by angiotensin II, endothelin-1, and thrombin.
Taylor DS; Cheng X; Pawlowski JE; Wallace AR; Ferrer P; Molloy CJ
Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1633-8. PubMed ID: 9990076
[TBL] [Abstract][Full Text] [Related]
29. Role of the C-terminal linear region of EGF-like growth factors in ErbB specificity.
van der Woning SP; Venselaar H; van Rotterdam W; Jacobs-Oomen S; van Leeuwen JE; van Zoelen EJ
Growth Factors; 2009 Jun; 27(3):163-72. PubMed ID: 19384683
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of EGFR ligands on endocytic sorting of the receptor.
Roepstorff K; Grandal MV; Henriksen L; Knudsen SL; Lerdrup M; Grøvdal L; Willumsen BM; van Deurs B
Traffic; 2009 Aug; 10(8):1115-27. PubMed ID: 19531065
[TBL] [Abstract][Full Text] [Related]
31. Epiregulin promotes proliferation and migration of renal proximal tubular cells.
Zhuang S; Yan Y; Daubert RA; Schnellmann RG
Am J Physiol Renal Physiol; 2007 Jul; 293(1):F219-26. PubMed ID: 17389679
[TBL] [Abstract][Full Text] [Related]
32. Binding specificities and affinities of egf domains for ErbB receptors.
Jones JT; Akita RW; Sliwkowski MX
FEBS Lett; 1999 Mar; 447(2-3):227-31. PubMed ID: 10214951
[TBL] [Abstract][Full Text] [Related]
33. Solution structure of epiregulin and the effect of its C-terminal domain for receptor binding affinity.
Sato K; Nakamura T; Mizuguchi M; Miura K; Tada M; Aizawa T; Gomi T; Miyamoto K; Kawano K
FEBS Lett; 2003 Oct; 553(3):232-8. PubMed ID: 14572630
[TBL] [Abstract][Full Text] [Related]
34. Functional selectivity of EGF family peptide growth factors: implications for cancer.
Wilson KJ; Gilmore JL; Foley J; Lemmon MA; Riese DJ
Pharmacol Ther; 2009 Apr; 122(1):1-8. PubMed ID: 19135477
[TBL] [Abstract][Full Text] [Related]
35. Human corneal epithelial cell proliferation by epiregulin and its cross-induction by other EGF family members.
Morita S; Shirakata Y; Shiraishi A; Kadota Y; Hashimoto K; Higashiyama S; Ohashi Y
Mol Vis; 2007 Nov; 13():2119-28. PubMed ID: 18079685
[TBL] [Abstract][Full Text] [Related]
36. Fractalkine has anti-apoptotic and proliferative effects on human vascular smooth muscle cells via epidermal growth factor receptor signalling.
White GE; Tan TC; John AE; Whatling C; McPheat WL; Greaves DR
Cardiovasc Res; 2010 Mar; 85(4):825-35. PubMed ID: 19840952
[TBL] [Abstract][Full Text] [Related]
37. The expression of epidermal growth factor receptors and their ligands (epidermal growth factor, neuregulin, amphiregulin) in the bitch uterus during the estrus cycle.
Sağsöz H; Liman N; Saruhan BG; Küçükaslan İ
Anim Reprod Sci; 2014 Jun; 147(3-4):161-79. PubMed ID: 24813021
[TBL] [Abstract][Full Text] [Related]
38. Epiregulin stimulates proliferation of rabbit gastric cells in primary culture through autophosphorylation of the epidermal growth factor receptor.
Sasaki E; Arakawa T; Fujiwara Y; Kawada N; Fukuda T; Higuchi K; Komurasaki T; Kobayashi K
Eur J Pharmacol; 1997 Nov; 338(3):253-8. PubMed ID: 9424019
[TBL] [Abstract][Full Text] [Related]
39. The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4.
Riese DJ; Kim ED; Elenius K; Buckley S; Klagsbrun M; Plowman GD; Stern DF
J Biol Chem; 1996 Aug; 271(33):20047-52. PubMed ID: 8702723
[TBL] [Abstract][Full Text] [Related]
40. The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein.
Lucas LM; Dwivedi V; Senfeld JI; Cullum RL; Mill CP; Piazza JT; Bryant IN; Cook LJ; Miller ST; Lott JH; Kelley CM; Knerr EL; Markham JA; Kaufmann DP; Jacobi MA; Shen J; Riese DJ
Pharmacol Rev; 2022 Jan; 74(1):18-47. PubMed ID: 34987087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
